Personalized management of hypertensive patients: focus on prognostic biomarkers
Aim. To analyze level of circulating biomarkers of plasma vascular endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) during 3-month therapy with a fixed-dose combination of ramipril/indapamide (Konsilar-D24, AO Vertex, Russia), as well as to evaluate the antihypertensive efficacy...
Saved in:
| Main Authors: | S. V. Lyamina, S. V. Kalish, N. P. Lyamina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2022-05-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01) -
Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program
by: A. O. Konradi, et al.
Published: (2021-10-01) -
Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
by: A. O. Konradi, et al.
Published: (2025-02-01) -
Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
by: Yu. A. Karpov, et al.
Published: (2020-11-01) -
Effects of fixed-dose indapamide/perindopril combination on arterial function in patients with hypertension and chronic kidney disease: key results of the CAMERTON program
by: Zh. D. Kobalava, et al.
Published: (2019-12-01)